HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hachiro Sugimoto Selected Research

orange oil

1/2020Aromatherapy improves cognitive dysfunction in senescence-accelerated mouse prone 8 by reducing the level of amyloid beta and tau phosphorylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hachiro Sugimoto Research Topics

Disease

27Alzheimer Disease (Alzheimer's Disease)
01/2020 - 05/2002
3Cognitive Dysfunction
01/2020 - 01/2017
3Tauopathies
12/2015 - 09/2012
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2022 - 03/2010
2Neuroblastoma
01/2020 - 01/2017
2Amyloid Plaque
10/2016 - 02/2008
2Parkinson Disease (Parkinson's Disease)
09/2012 - 11/2005
2Glioma (Gliomas)
04/2010 - 01/2008
2Ischemia
06/2008 - 04/2008
1Dementia (Dementias)
01/2020
1Neoplasms (Cancer)
09/2011
1Arthritis (Polyarthritis)
03/2011
1Stroke (Strokes)
03/2010
1Diabetic Nephropathies (Diabetic Nephropathy)
02/2009
1Neurodegenerative Diseases (Neurodegenerative Disease)
06/2008
1Brain Ischemia (Cerebral Ischemia)
05/2008
1Infarction (Infarctions)
05/2008
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
12/2006
1Central Nervous System Diseases (CNS Diseases)
10/2006

Drug/Important Bio-Agent (IBA)

13Amyloid (Amyloid Fibrils)IBA
01/2020 - 03/2008
10Amyloid beta-PeptidesIBA
01/2020 - 12/2006
8Proteins (Proteins, Gene)FDA Link
01/2020 - 05/2008
5CurcuminIBA
11/2022 - 04/2010
4Therapeutic UsesIBA
11/2022 - 03/2009
4Peptides (Polypeptides)IBA
01/2020 - 01/2015
4Donepezil (Aricept)FDA LinkGeneric
03/2009 - 08/2003
4Glutamic Acid (Glutamate)FDA Link
06/2008 - 09/2006
3Cholinesterase Inhibitors (Anticholinesterases)IBA
03/2009 - 09/2006
3serofendic acidIBA
02/2009 - 11/2005
3Cholinergic Agents (Cholinergics)IBA
09/2008 - 03/2008
2tau Proteins (tau Protein)IBA
10/2016 - 10/2014
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2015 - 09/2012
2Presenilin-1IBA
01/2015 - 09/2008
2Leucine (L-Leucine)FDA Link
04/2010 - 01/2008
2Tacrine (Cognex)FDA Link
03/2009 - 09/2006
2Cholinesterases (Cholinesterase)IBA
09/2008 - 05/2002
1pyrazoleIBA
11/2022
1orange oilIBA
01/2020
1rosemary oilIBA
01/2020
1Cysteine (L-Cysteine)FDA Link
12/2015
1RotenoneIBA
09/2012
1Collagen Type II (Type II Collagen)IBA
03/2011
1Metalloproteases (Metalloproteinases)IBA
04/2010
1Amino Acid Transport System X-AG (Glutamate Transporter)IBA
03/2010
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2009
1Galantamine (Galanthamine)FDA LinkGeneric
03/2009
1Acetylcholine (Acetylcholine Chloride)FDA Link
03/2009
1Bromodeoxyuridine (BrdU)IBA
09/2008
1Neurotransmitter Agents (Neurotransmitter)IBA
06/2008
1Free Radical ScavengersIBA
05/2008
1EdaravoneIBA
05/2008
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
05/2008
1EnzymesIBA
05/2008
1Excitatory Amino AcidsIBA
04/2008
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
04/2008
1Glutamate Receptors (Glutamate Receptor)IBA
04/2008
1PropionatesIBA
04/2008
1myricetinIBA
02/2008
1Carrier Proteins (Binding Protein)IBA
01/2008
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2006
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
09/2006
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
09/2006
1Cadherins (E-Cadherin)IBA
07/2006
1beta CateninIBA
07/2006
1AcetylcholinesteraseIBA
08/2003

Therapy/Procedure

2Therapeutics
09/2011 - 10/2006
1Aromatherapy
01/2020